While early liquid biopsy approaches focused on single genes such as epidermal growth factor receptor (EGFR) [23], these have rapidly been eclipsed by multigene assays, given the growing number of actionable biomarkers both at lung cancer diagnosis and for treatment resistance. This evidence concerns the gene EGFR and lung cancer.